Boston Biomedical Associates
6
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
33.3%
2 terminated/withdrawn out of 6 trials
60.0%
-26.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
Role: lead
Cardiovalve Transfemoral Mitral Valve System
Role: lead
A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals
Role: collaborator
Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population
Role: collaborator
Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3)
Role: collaborator
Delphinus SoftVue™ ROC Reader Study
Role: collaborator
All 6 trials loaded